Comparison of tenofovir, zidovudine, or stavudine as part of first-line antiretroviral therapy in a resource-limited-setting: a cohort study.
Tenofovir (TDF) is part of the WHO recommended first-line antiretroviral therapy (ART); however, there are limited data comparing TDF to other nucleoside reverse transcriptase inhibitors in resource-limited-settings. Using a routine workplace and community-based ART cohort in South Africa, we assess...
Main Authors: | Kavindhran Velen, James J Lewis, Salome Charalambous, Alison D Grant, Gavin J Churchyard, Christopher J Hoffmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3653880?pdf=render |
Similar Items
-
Development of Severe Anemia and Changes in Hemoglobin in a Cohort of HIV-Infected Ugandan Adults Receiving Zidovudine-, Stavudine-, and Tenofovir-Containing Antiretroviral Regimens
by: Rosalind Parkes-Ratanshi, et al.
Published: (2015-09-01) -
Risk factors of treatment-limiting anemia after substitution of zidovudine for stavudine in HIV-infected adult patients on antiretroviral treatment.
by: Thong Phe, et al.
Published: (2013-01-01) -
Stability-indicating methods for quantitative determination of zidovudine and stavudine in capsules
by: Maria Inês R. M. Santoro, et al.
Published: (2006-04-01) -
Tuberculosis in prisons: an unintended sentence?
by: Kavindhran Velen, et al.
Published: (2021-05-01) -
The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes.
by: Lachlan R Gray, et al.
Published: (2013-01-01)